Bharat Biotech’s intranasal vaccine iNCOVACC will get CDSCO approval for heterologous booster doses
Bharat Biotech Worldwide Restricted (BBIL), a worldwide vaccine producer, introduced on Monday that the Central Medication Normal Management Group (CDSCO) in India had authorised the usage of the heterologous booster doses of the Covid…